Raymond Lifestyle
Raymond Lifestyle delivered a strong FY26 with total income of ₹7,034 crore (+11% YoY) and EBITDA of ₹804 crore (+23% YoY), marking the highest ever.
Raymond Lifestyle vs Ajanta Pharma Q4 FY26
Side-by-side earnings comparison across verified financials, sentiment, risks, and management commentary.
Ajanta Pharma
Ajanta Pharma delivered a strong Q4 FY26 with revenue of ₹1,422 crore (+21% YoY) and PAT of ₹267 crore (+18% YoY).
Result Snapshot
Revenue₹1,776 Cr₹1,422 Cr
PAT₹-52 Cr₹267 Cr
EBITDA Margin7%23%
Sentimentbullishbullish
Key Quotes
We crossed 7,000 cr recording our highest ever total income of 7034 crores and 11% year-on-year growth.
Our revenue from operations grew by 21%. While margins grew by 18%. Reflecting strong operating performance alongside continued investments to support future growth.